The Staging of Malignant Pleural Mesothelioma.
Euhus CJ, Ripley RT.
Thorac Surg Clin. 2020 Nov;30(4):425-433. doi: 10.1016/j.thorsurg.2020.07.001. Epub 2020 Sep 12.
Pericardial Mesotheliomas.
Arrossi AV.
Adv Anat Pathol. 2023 Jul 1;30(4):253-258. doi: 10.1097/PAP.0000000000000399. Epub 2023 Apr 27.
Diagnosis and treatment of malignant pleural mesothelioma.
Rodríguez Panadero F.
Arch Bronconeumol. 2015 Apr;51(4):177-84. doi: 10.1016/j.arbres.2014.06.005. Epub 2014 Jul 22.
Malignant pleural mesothelioma in Singapore.
Yip CS, Koong HN, Loo CM, Fong KW.
Asian Pac J Cancer Prev. 2011;12(5):1155-9.
Rapidly progressing metastatic malignant melanoma mimicking primary pleural tumor: A case report.
So C, Yoshida T, Mizuno T, Yatabe Y, Ohe Y.
Thorac Cancer. 2022 May;13(9):1423-1426. doi: 10.1111/1759-7714.14392. Epub 2022 Mar 21.
Thoracoscopic assessment of pleural tumor burden in patients with malignant pleural effusion: prognostic and therapeutic implications.
Sakr L, Maldonado F, Greillier L, Dutau H, Loundou A, Astoul P.
J Thorac Oncol. 2011 Mar;6(3):592-7. doi: 10.1097/JTO.0b013e318208c7c1.
Malignant pleural mesothelioma.
Schouwink H, Baas P, Rutgers ET, Zoetmulder FA.
Eur Respir J. 1999 Mar;13(3):706. doi: 10.1183/09031936.99.13370699.
RECURRENT MALIGNANT PLEURAL EFFUSIONS.
STARKEY GW.
N Engl J Med. 1964 Feb 27;270:436-8. doi: 10.1056/NEJM196402272700902.
Prognostic significance of soluble mesothelin in malignant pleural mesothelioma: a meta-analysis.
Tian L, Zeng R, Wang X, Shen C, Lai Y, Wang M, Che G.
Oncotarget. 2017 Jul 11;8(28):46425-46435. doi: 10.18632/oncotarget.17436.
Detection of Circulating Tumor Cells (CTCs) in Malignant Pleural Mesothelioma (MPM) with the "Universal" CTC-Chip and An Anti-Podoplanin Antibody NZ-1.2.
Kuwata T, Yoneda K, Mori M, Kanayama M, Kuroda K, Kaneko MK, Kato Y, Tanaka F.
Cells. 2020 Apr 5;9(4):888. doi: 10.3390/cells9040888.
